Healthy men help scientists track how new drug leaves the body
NCT ID NCT07218744
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 35 times
Summary
This study looked at how a single dose of a drug called INCB123667 is absorbed, broken down, and removed from the body in 9 healthy men aged 18 to 55. Participants took the drug by mouth, and researchers measured radioactivity in blood, urine, and stool to track the drug's path. The goal was to understand the drug's metabolism and excretion, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.